India · Delayed Price · Currency is INR Vivimed Labs Statistics
Total Valuation
Vivimed Labs has a market cap or net worth of INR 421.20 million. The enterprise value is 4.38 billion.
| Market Cap | 421.20M |
| Enterprise Value | 4.38B |
Important Dates
The last earnings date was Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivimed Labs has 82.91 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 82.91M |
| Shares Outstanding | 82.91M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 11.57% |
| Owned by Institutions (%) | 6.94% |
| Float | 64.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | -0.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.23 |
| P/OCF Ratio | 5.47 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 64.84 |
Financial Position
The company has a current ratio of 0.37
| Current Ratio | 0.37 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 58.81 |
| Interest Coverage | -41.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -12.85% |
| Return on Invested Capital (ROIC) | -56.38% |
| Return on Capital Employed (ROCE) | -56.38% |
| Weighted Average Cost of Capital (WACC) | 1.54% |
| Revenue Per Employee | 1.30M |
| Profits Per Employee | -3.01M |
| Employee Count | 586 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, Vivimed Labs has paid 1.37 million in taxes.
| Income Tax | 1.37M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.74 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.81 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 34.58 |
| Average Volume (20 Days) | 60,682 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vivimed Labs had revenue of INR 763.08 million and -1.76 billion in losses. Loss per share was -21.15.
| Revenue | 763.08M |
| Gross Profit | 25.61M |
| Operating Income | -1.72B |
| Pretax Income | -1.76B |
| Net Income | -1.76B |
| EBITDA | -1.46B |
| EBIT | -1.72B |
| Loss Per Share | -21.15 |
Balance Sheet
The company has 13.56 million in cash and 3.97 billion in debt, with a net cash position of -3.96 billion or -47.76 per share.
| Cash & Cash Equivalents | 13.56M |
| Total Debt | 3.97B |
| Net Cash | -3.96B |
| Net Cash Per Share | -47.76 |
| Equity (Book Value) | -2.11B |
| Book Value Per Share | -25.39 |
| Working Capital | -2.80B |
Cash Flow
In the last 12 months, operating cash flow was 77.03 million and capital expenditures -9.47 million, giving a free cash flow of 67.56 million.
| Operating Cash Flow | 77.03M |
| Capital Expenditures | -9.47M |
| Depreciation & Amortization | 260.52M |
| Net Borrowing | -19.36M |
| Free Cash Flow | 67.56M |
| FCF Per Share | 0.81 |
Margins
Gross margin is 3.36%, with operating and profit margins of -225.62% and -231.26%.
| Gross Margin | 3.36% |
| Operating Margin | -225.62% |
| Pretax Margin | -231.08% |
| Profit Margin | -231.26% |
| EBITDA Margin | -191.48% |
| EBIT Margin | -225.62% |
| FCF Margin | 8.85% |
Dividends & Yields
Vivimed Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | -418.97% |
| FCF Yield | 16.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 6, 2016. It was a forward split with a ratio of 5.
| Last Split Date | Apr 6, 2016 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |